Cypress Wealth Services, LLC Amgen Inc Transaction History

Cypress Wealth Services, LLC

$468 Million
Q3 2024

A detailed history of Cypress Wealth Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cypress Wealth Services, LLC holds 3,121 shares of AMGN stock, worth $919,228. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,121

Previous 3,072 1.6%

Holding current value

$919,228

Previous $959,000 4.8%

% of portfolio

0.21%

Previous 0.22%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $15,159 - $16,531	49 Added 1.6%	3,121 $1.01 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $7,882 - $9,579	30 Added 0.99%	3,072 $959,000
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $61,302 - $73,999	228 Added 8.1%	3,042 $864,000
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $4,602 - $5,192	-18 Reduced 0.64%	2,814 $810,000
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $40,497 - $47,886	189 Added 7.15%	2,832 $628,000
Q1 2023 Apr 07, 2023	SELL	$225.79 - $275.2 $388,358 - $473,344	-1,720 Reduced 39.42%	2,643 $638,000
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $10,306 - $13,095	45 Added 1.04%	4,363 $0
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $4,040 - $4,556	18 Added 0.42%	4,318 $989,000
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $46,142 - $51,348	200 Added 4.88%	4,300 $1.05 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $44,073 - $48,756	201 Added 5.16%	4,100 $991,000
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $25,456 - $29,132	128 Added 3.39%	3,899 $877,000
Q3 2021 Oct 13, 2021	SELL	$212.27 - $248.7 $412,865 - $483,721	-1,945 Reduced 34.03%	3,771 $802,000
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $36,672 - $40,684	-157 Reduced 2.67%	5,716 $1.39 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $7,323 - $8,533	33 Added 0.57%	5,873 $1.46 Million
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $33,755 - $40,196	-156 Reduced 2.6%	5,840 $1.34 Million
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $29,275 - $35,925	148 Added 2.53%	5,996 $1.41 Million
Q1 2020 Apr 10, 2020	SELL	$182.24 - $241.7 $33,349 - $44,231	-183 Reduced 3.03%	5,848 $1.19 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $151,935 - $195,289	-803 Reduced 11.75%	6,031 $1.45 Million
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $2,611 - $3,129	-15 Reduced 0.22%	6,834 $1.32 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $17,503 - $20,518	105 Added 1.56%	6,849 $1.26 Million
Q1 2019 Apr 19, 2019	BUY	$180.87 - $203.88 $603,744 - $680,551	3,338 Added 98.0%	6,744 $1.28 Million
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $95,087 - $110,997	-533 Reduced 13.53%	3,406 $663,000
Q3 2018 Oct 19, 2018	BUY	$185.29 - $208.89 $13,526 - $15,248	73 Added 1.89%	3,939 $817,000
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $245,421 - $275,661	1,478 Added 61.89%	3,866 $714,000
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $53,539 - $62,568	-316 Reduced 11.69%	2,388 $407,000
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $456,408 - $509,947	2,704	2,704 $470,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Wealth Services, LLC with notifications on news.

Account

Cypress Wealth Services, LLC Amgen Inc Transaction History